Additional file 4: of A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
- Wan-Hong Zhao (6109325)
- Jie Liu (15128)
- Bai-Yan Wang (6109328)
- Yin-Xia Chen (6109331)
- Xing-Mei Cao (6109334)
- Yun Yang (417125)
- Yi-Lin Zhang (276278)
- Fang-Xia Wang (6109337)
- Peng-Yu Zhang (6109340)
- Bo Lei (310282)
- Liu-Fang Gu (6109343)
- Jian-Li Wang (1631008)
- Nan Yang (305078)
- Ru Zhang (431993)
- Hui Zhang (7197)
- Ying Shen (48310)
- Ju Bai (6109346)
- Yan Xu (14594)
- Xu-Geng Wang (6109349)
- Rui-Li Zhang (675458)
- Li-Li Wei (6109352)
- Zong-Fang Li (540741)
- Zhen-Zhen Li (4046321)
- Yan Geng (268097)
- Qian He (248656)
- Qiu-Chuan Zhuang (6109355)
- Xiao-Hu Fan (6109358)
- Ai-Li He (6109361)
- Wang-Gang Zhang (6109364)
Publication date
December 2018
DOIAbstract
Relationship between dose and response. Relationship between CAR+ cell dose and complete response. (DOCX 80Â kb
Add to ORKG